中东和非洲碳青霉烯类抗生素市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（美罗培南、多尼培南、亚胺培南、替比培南等）、适应症（细菌性脑膜炎、急性盆腔感染、呼吸道感染、体内感染））腹部感染、尿路感染等）和分销渠道（零售药店、网上药店、医院药房）
No. of Pages: 116 | Report Code: TIPRE00028814 | Category: Life Sciences
No. of Pages: 116 | Report Code: TIPRE00028814 | Category: Life Sciences
中东和非洲碳青霉烯类抗生素市场预计将从2021年的2.3742亿美元增至2028年的2.972亿美元；预计 2021 年至 2028 年复合年增长率为 3.3%。
市场的增长归因于细菌感染流行率上升以及领先制药企业的私人和公共合作伙伴关系的增加等因素。然而，开发抗生素的繁琐且昂贵的过程预计将在预测期内抑制市场的增长。
制药行业的技术发展带来了巨大的发展和更好的治疗。制药行业已经融入深度学习、人工智能（AI）和机器学习等智能技术来开发新的抗生素。研究人员正在努力建立用于识别新抗生素的工具和平台。预计新抗生素发现中的新技术将改变整个抗生素市场。然而，开发针对革兰氏阴性菌的抗生素具有挑战性，因为各种药物仍在开发中。
抗生素开发的主要挑战是分子穿过细菌包膜的渗透性有限。然而，革兰氏阴性细菌具有营养特异性蛋白质通道（孔蛋白），可限制非必需分子（包括抗生素）的渗透性。渗透性使研究人员能够开发出一种称为计算抗生素筛选（CLASP）的新平台，该平台有助于通过孔蛋白识别潜在的药物分子。
CLASP 具有粗粒度 (CG) 分辨率、先进的采样技术以及可最大限度提高其性能的并行计算环境的优势。它可以在几个小时内提供正在研究的潜在药物分子的完整热力学和动力学结果。它有助于理解或识别产生结构-性质关系的小分子库，以发现具有高渗透性的抗生素。因此，预计 CLASP 将加速治疗革兰氏阴性菌感染的新型抗生素药物的发展，从而进一步带动市场的显着增长。
此外，仿制药还有由于其可用性和负担能力而受欢迎。此外，碳青霉烯类抗生素专利的到期为仿制药制造商提供了以具有成本效益的药物进入市场的更多机会。 因此，企业正在加速仿制药生产并推动仿制药生产。中东碳青霉烯类抗生素市场。
Strategic insights for Middle East and Africa Carbapenem-Based Antibiotics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 237.42 Million |
| Market Size by 2028 | US$ 297.20 Million |
| Global CAGR (2021 - 2028) | 3.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Carbapenem-Based Antibiotics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Carbapenem-Based Antibiotics Market is valued at US$ 237.42 Million in 2021, it is projected to reach US$ 297.20 Million by 2028.
As per our report Middle East and Africa Carbapenem-Based Antibiotics Market, the market size is valued at US$ 237.42 Million in 2021, projecting it to reach US$ 297.20 Million by 2028. This translates to a CAGR of approximately 3.3% during the forecast period.
The Middle East and Africa Carbapenem-Based Antibiotics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Carbapenem-Based Antibiotics Market report:
The Middle East and Africa Carbapenem-Based Antibiotics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Carbapenem-Based Antibiotics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Carbapenem-Based Antibiotics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Carbapenem-Based Antibiotics Market
